Clin2
NCT06793098Possibly a fitRecruiting

Functional proteins in polycystic ovary syndrome

Reproductive AgePCOS (Polycystic Ovary Syndrome)

Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.

This study measures proteins in the blood that may be linked to polycystic ovary syndrome (PCOS). It aims to find differences between women with PCOS and those without, which could lead to better understanding and diagnosis.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
18 years to 45 years
Study type
Observational

Who can take part

  • You are between 18 and 45 years old.
  • You have not had one or both ovaries removed.
  • You do not have diabetes that is being treated.
  • You do not have other treated metabolic diseases (like problems with how your body processes food or energy).
  • You do not have treated autoimmune or autoinflammatory diseases.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06793085Recruiting
Inflammation Proteins in PCOS Study

This study looks at inflammation-related proteins in women with PCOS to understand what causes the condition. If eligible, you’d help researchers learn more about PCOS, which could lead to better treatments.

Krakow
NCT06793072Recruiting
Adipokines in PCOS trial

This study looks at certain proteins (adipokines) in the blood of people with polycystic ovary syndrome (PCOS) to see how they relate to the condition. It may help researchers better understand PCOS.

Krakow
NCT07227363Recruiting
Keto diet for PCOS symptoms pilot study

This study tests if a keto diet can improve symptoms of PCOS. You'll follow your normal routine while researchers monitor changes.

Columbus, Ohio
NCT07616037Recruiting· Phase 2
New hormone treatment for polycystic ovary syndrome

This study tests a new medication that combines two hormone-like drugs to treat polycystic ovary syndrome (PCOS), a condition affecting ovulation and hormone balance. The trial aims to see if this dual-action drug can improve irregular periods and other PCOS symptoms better than current treatments.

Shanghai, Shanghai Municipality
NCT06545994Recruiting
Studying kisspeptin hormone levels in PCOS pregnancy

This study looks at a hormone called kisspeptin in pregnant women with PCOS. It aims to understand how this hormone changes during pregnancy, which may help improve care for women with PCOS.

Shanghai, Shanghai Municipality
NCT07094776Enrolling by invitation
MG53 protein levels in women with PCOS

This study measures a protein called MG53 in the blood of women with and without PCOS to see if it could be a marker for the condition. If you have PCOS and are not taking certain medications, you may be able to join and help researchers better understand the disease.

Gaziosmanpaşa, Istanbul

Hear when a new Reproductive Age trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.